ID

39317

Description

Combined Rituximab and Lenalidomide Treatment for Untreated Patients With Follicular Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT01476787

Link

https://clinicaltrials.gov/show/NCT01476787

Keywords

Versions (1)
  1. 12/19/19 12/19/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

December 19, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Follicular Lymphoma NCT01476787

English

Eligibility Follicular Lymphoma NCT01476787

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed follicular lymphoma grade 1, 2 or 3a, stage ii-iv
Description

Follicular Lymphoma Grade | Follicular Lymphoma Ann Arbor lymphoma staging system

Data type

boolean

Alias
UMLS CUI [1,1]
C0024301
UMLS CUI [1,2]
C0441800
UMLS CUI [2,1]
C0024301
UMLS CUI [2,2]
C0432516
have no prior systemic treatment for lymphoma
Description

Systemic therapy Absent Lymphoma

Data type

boolean

Alias
UMLS CUI [1,1]
C1515119
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C0024299
symptomatic follicular lymphoma requiring treatment.
Description

Follicular Lymphoma Symptomatic Treatment required for

Data type

boolean

Alias
UMLS CUI [1,1]
C0024301
UMLS CUI [1,2]
C0231220
UMLS CUI [1,3]
C0332121
age ≥18 years
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
eastern cooperative oncology group performance status 0-2
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
willing to follow pregnancy precautions
Description

Contraceptive methods Willing

Data type

boolean

Alias
UMLS CUI [1,1]
C0700589
UMLS CUI [1,2]
C0600109
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
clinical evidence of transformed lymphoma or grade 3b follicular lymphoma.
Description

Lymphoma transformation | Follicular Lymphoma Grade

Data type

boolean

Alias
UMLS CUI [1,1]
C0024299
UMLS CUI [1,2]
C0040682
UMLS CUI [2,1]
C0024301
UMLS CUI [2,2]
C0441800
major surgery (excluding lymph node biopsy) within 28 days prior to signing informed consent.
Description

Major surgery | Exception Biopsy of lymph node

Data type

boolean

Alias
UMLS CUI [1]
C0679637
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0193842
known seropositive for or active viral infection with hepatitis b virus (hbv), hepatitis c virus (hcv), human immunodeficiency virus (hiv)
Description

Serology positive Hepatitis B | Serology positive Hepatitis C | HIV Seropositivity

Data type

boolean

Alias
UMLS CUI [1,1]
C0242089
UMLS CUI [1,2]
C0019163
UMLS CUI [2,1]
C0242089
UMLS CUI [2,2]
C0019196
UMLS CUI [3]
C0019699
known sensitivity or allergy to murine products.
Description

Hypersensitivity Product Murine

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1254351
UMLS CUI [1,3]
C0026809
presence or history of central nervous system involvement by lymphoma
Description

Central Nervous System Involvement Lymphoma

Data type

boolean

Alias
UMLS CUI [1,1]
C4050309
UMLS CUI [1,2]
C0024299
at high risk for a venous thromboembolic event (vte) and not willing to take vte prophylaxis
Description

High risk of Venous Thromboembolism | Prophylactic treatment Unwilling Venous Thromboembolism

Data type

boolean

Alias
UMLS CUI [1,1]
C0332167
UMLS CUI [1,2]
C1861172
UMLS CUI [2,1]
C0199176
UMLS CUI [2,2]
C0558080
UMLS CUI [2,3]
C1861172
any of the following laboratory abnormalities:
Description

LABORATORY ABNORMALITIES

Data type

boolean

Alias
UMLS CUI [1]
C1853129
serum aspartate transaminase or alanine transaminase > 3x upper limit of normal (uln), except in patients with documented liver involvement by lymphoma
Description

Aspartate aminotransferase increased | Alanine aminotransferase increased | Exception Liver Involvement with Lymphoma

Data type

boolean

Alias
UMLS CUI [1]
C0151904
UMLS CUI [2]
C0151905
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0023884
UMLS CUI [3,3]
C1314939
UMLS CUI [3,4]
C0024299
total bilirubin > 2.0 mg/dl (34 µmol/l) except in cases of gilberts syndrome and documented liver or pancreatic involvement by lymphoma
Description

Serum total bilirubin measurement | Exception Gilbert Disease | Exception Liver Involvement with Lymphoma | Exception Pancreas Involvement with Lymphoma

Data type

boolean

Alias
UMLS CUI [1]
C1278039
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0017551
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0023884
UMLS CUI [3,3]
C1314939
UMLS CUI [3,4]
C0024299
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0030274
UMLS CUI [4,3]
C1314939
UMLS CUI [4,4]
C0024299
creatinine clearance of < 30 ml/min
Description

Creatinine clearance measurement

Data type

boolean

Alias
UMLS CUI [1]
C0373595
Back to the top of the page

Similar models

Eligibility Follicular Lymphoma NCT01476787

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Follicular Lymphoma Grade | Follicular Lymphoma Ann Arbor lymphoma staging system
Item
histologically confirmed follicular lymphoma grade 1, 2 or 3a, stage ii-iv
boolean
C0024301 (UMLS CUI [1,1])
C0441800 (UMLS CUI [1,2])
C0024301 (UMLS CUI [2,1])
C0432516 (UMLS CUI [2,2])
Systemic therapy Absent Lymphoma
Item
have no prior systemic treatment for lymphoma
boolean
C1515119 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0024299 (UMLS CUI [1,3])
Follicular Lymphoma Symptomatic Treatment required for
Item
symptomatic follicular lymphoma requiring treatment.
boolean
C0024301 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C0332121 (UMLS CUI [1,3])
Age
Item
age ≥18 years
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
eastern cooperative oncology group performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Contraceptive methods Willing
Item
willing to follow pregnancy precautions
boolean
C0700589 (UMLS CUI [1,1])
C0600109 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Lymphoma transformation | Follicular Lymphoma Grade
Item
clinical evidence of transformed lymphoma or grade 3b follicular lymphoma.
boolean
C0024299 (UMLS CUI [1,1])
C0040682 (UMLS CUI [1,2])
C0024301 (UMLS CUI [2,1])
C0441800 (UMLS CUI [2,2])
Major surgery | Exception Biopsy of lymph node
Item
major surgery (excluding lymph node biopsy) within 28 days prior to signing informed consent.
boolean
C0679637 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0193842 (UMLS CUI [2,2])
Serology positive Hepatitis B | Serology positive Hepatitis C | HIV Seropositivity
Item
known seropositive for or active viral infection with hepatitis b virus (hbv), hepatitis c virus (hcv), human immunodeficiency virus (hiv)
boolean
C0242089 (UMLS CUI [1,1])
C0019163 (UMLS CUI [1,2])
C0242089 (UMLS CUI [2,1])
C0019196 (UMLS CUI [2,2])
C0019699 (UMLS CUI [3])
Hypersensitivity Product Murine
Item
known sensitivity or allergy to murine products.
boolean
C0020517 (UMLS CUI [1,1])
C1254351 (UMLS CUI [1,2])
C0026809 (UMLS CUI [1,3])
Central Nervous System Involvement Lymphoma
Item
presence or history of central nervous system involvement by lymphoma
boolean
C4050309 (UMLS CUI [1,1])
C0024299 (UMLS CUI [1,2])
High risk of Venous Thromboembolism | Prophylactic treatment Unwilling Venous Thromboembolism
Item
at high risk for a venous thromboembolic event (vte) and not willing to take vte prophylaxis
boolean
C0332167 (UMLS CUI [1,1])
C1861172 (UMLS CUI [1,2])
C0199176 (UMLS CUI [2,1])
C0558080 (UMLS CUI [2,2])
C1861172 (UMLS CUI [2,3])
LABORATORY ABNORMALITIES
Item
any of the following laboratory abnormalities:
boolean
C1853129 (UMLS CUI [1])
Aspartate aminotransferase increased | Alanine aminotransferase increased | Exception Liver Involvement with Lymphoma
Item
serum aspartate transaminase or alanine transaminase > 3x upper limit of normal (uln), except in patients with documented liver involvement by lymphoma
boolean
C0151904 (UMLS CUI [1])
C0151905 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0023884 (UMLS CUI [3,2])
C1314939 (UMLS CUI [3,3])
C0024299 (UMLS CUI [3,4])
Serum total bilirubin measurement | Exception Gilbert Disease | Exception Liver Involvement with Lymphoma | Exception Pancreas Involvement with Lymphoma
Item
total bilirubin > 2.0 mg/dl (34 µmol/l) except in cases of gilberts syndrome and documented liver or pancreatic involvement by lymphoma
boolean
C1278039 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0017551 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0023884 (UMLS CUI [3,2])
C1314939 (UMLS CUI [3,3])
C0024299 (UMLS CUI [3,4])
C1705847 (UMLS CUI [4,1])
C0030274 (UMLS CUI [4,2])
C1314939 (UMLS CUI [4,3])
C0024299 (UMLS CUI [4,4])
Creatinine clearance measurement
Item
creatinine clearance of < 30 ml/min
boolean
C0373595 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial